Oculofacial Plastic & Reconstructive Surgery, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
Oculofacial Plastic & Reconstructive Surgery, Dean McGee Eye Institute, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.
Ophthalmic Plast Reconstr Surg. 2021;37(3):284-289. doi: 10.1097/IOP.0000000000001829.
Complex bony orbital defects are reconstructively challenging due to loss of intraoperative anatomical landmarks and adjacent support. Presized and precontoured porous polyethylene-titanium implants (Medpor Titan 3D Orbital Floor Implant) are designed to reestablish normal orbital floor and medial wall anatomy and are modeled after anatomically averaged orbits. This is the first study to report clinical outcomes with this implant.
This retrospective case series reviewed clinical data and outcomes for patients undergoing orbital reconstruction with a presized and precontoured porous polyethylene-titanium orbital implant from January 2016 to June 2018.
A total of 34 orbits of 33 patients were identified (mean age: 43 ± 16 years, 70% men). Most bony defects were a result of trauma and included large orbital floor deformities (100%), medial wall defects (74%), disrupted inferomedial struts (68%), and broken posterior ledges (82%). Symptomatic diplopia (73%) and enophthalmos (89%, mean: 3.7 ± 2.1 mm) were common preoperatively. Many cases were revisions (44%). Mean follow up was 7.8 ± 6.7 months. All patients had improved globe positioning, enophthalmos, and hypoglobus. Seven patients had persistent postoperative diplopia: 6 responded to prism therapy and 1 required strabismus surgery. One patient required retrobulbar hematoma drainage and 1 patient required implant explantation due to chronic infection.
Commercially available presized and precon toured porous polyethylene-titanium implants are useful for complex orbital bony defects and can achieve functional improve ments in diplopia, enophthalmos, and extraocular motility with a low incidence of postoperative complications or revisional surgery.
由于术中解剖标志丢失和相邻支撑物缺失,复杂的骨性眶部缺损在重建方面具有挑战性。预制和预成型多孔聚乙烯-钛植入物(Medpor Titan 3D 眶底植入物)旨在重建正常的眶底和内侧壁解剖结构,并根据解剖平均眼眶进行塑形。这是第一项报告使用该植入物的临床结果的研究。
本回顾性病例系列研究回顾了 2016 年 1 月至 2018 年 6 月期间接受预制和预成型多孔聚乙烯-钛眶部植入物进行眶部重建的患者的临床数据和结果。
共确定了 33 例患者的 34 只眼眶(平均年龄:43±16 岁,70%为男性)。大多数骨缺损是外伤所致,包括大的眶底畸形(100%)、内侧壁缺损(74%)、内侧下支柱破坏(68%)和后缘支骨折(82%)。术前常见的症状是复视(73%)和眼球内陷(89%,平均:3.7±2.1mm)。许多病例为翻修手术(44%)。平均随访时间为 7.8±6.7 个月。所有患者的眼球位置、眼球内陷和眼球下旋均得到改善。7 例患者术后仍存在复视:6 例对棱镜治疗有反应,1 例需要斜视手术。1 例患者需要球后血肿引流,1 例患者因慢性感染需要取出植入物。
市售的预制和预成型多孔聚乙烯-钛植入物可用于治疗复杂的眶部骨性缺损,并能在复视、眼球内陷和眼球运动方面实现功能改善,术后并发症或翻修手术的发生率较低。